HORBACH S P J M. Pandemic Publishing: Medical journals drastically speed up their publication process for Covid-19[J]. bioRxiv, 2020.
[2]
TALLEY N J. SARS-CoV-2, the medical profession, ventilator beds, and mortality predictions: Personal reflections of an Australian clinician[J]. Medical Journal of Australia, 2020, 212（7）: 302-303.
[3]
SANDLE T. Open access science? Looking at the two-sides. [EB/OL].（2020-12-13）[2020-08-09]. .
[4]
STM. COVID-19 research downloaded more than 150 million times, reports STM. [EB/OL].（2020-10-23）[2020-06-24]. .
[5]
EISEN M B, AKHMANOVA A, BEHRENS T E, et al. Publishing in the time of COVID-19[J]. eLife, 2020, 9: 57162.
[6]
THE MIT PRESS. Media alert: Forthcoming reviews from RAPID REVIEWS: COVID-19. [EB/OL].（2020-11-20）[2020-10-22]. .
[7]
CHAMBERS C. Registered Reports and PhD’s: What? Why? How? An interview with Chris Chambers. [EB/OL].（2020-07-01）[2019-06-18]. .
[8]
CHAMBERS C. What’s next for Registered Reports?.[EB/OL].（2020-12-12）[2019-09-10]. .
[9]
CALLAWAY. E. Will the pandemic permanently alter scientific publishing?. [EB/OL].（2020-08-04）[2020-06-03]. .
[10]
KAMEL E. Covid-19 accelerates the push for open access in research. [EB/OL].（2020-12-29）[2020-11-03]. .
[11]
LARIVIERE V, SHU F, SUGIMOTO C. The coronavirus （COVID-19）outbreak highlights serious deficiencies in scholarly communication. [EB/OL].（2020-06-14）[2020-03-05]. .
[12]
IOANNIDIS J P A. Coronavirus disease 2019: The harms of exaggerated information and non‐evidence‐based measures[J]. European Journal of Clinical Investigation, 2020, 50（4）: 13222.
[13]
ORANSKY I. NEJM, Lancet place expressions of concern on controversial studies of drugs for COVID-19. [EB/OL].（2020-09-07）[2020-06-02]. .
